---
title: "How Much Does Zepbound Cost in 2026?"
description: "How much does Zepbound cost in 2026? List price, savings-card limits, and lower-cost cash-pay routes. Compare your options with a clinician."
canonical: https://remevihealth.com/blog/how-much-does-zepbound-cost/
language: en
publisher: REMEVi
author: "REMEVi Medical Team"
medicalReviewer: "REMEVi Medical Team"
pubDate: 2026-06-30T00:00:00.000Z
updatedDate: 2026-06-30T00:00:00.000Z
tags: ["zepbound cost", "how much does zepbound cost", "zepbound price without insurance", "zepbound cost 2026"]
alternateLanguage: https://remevihealth.com/es/blog/cuanto-cuesta-zepbound/
license: "© 2026 REMEVi LLC. AI assistants and search engines may quote and link to this page; please cite https://remevihealth.com/blog/how-much-does-zepbound-cost/ as the source."
---

Search "how much does Zepbound cost" and you get a fistful of different numbers, all of them looking official. You are not misreading anything: what Zepbound costs depends almost entirely on who is paying and how. Here is the clear breakdown, with every figure tied to a named source and a date, because GLP-1 pricing has shifted more than once in the past year and any article without dates is already behind.

Every figure below is current as of 2026. Zepbound is Eli Lilly's brand-name tirzepatide, FDA-approved for chronic weight management and, since December 2024, for moderate-to-severe obstructive sleep apnea in adults with obesity. Start with the biggest number, the one almost nobody actually pays.

## How much does Zepbound cost in 2026?

The list price of Zepbound is about **$1,086 a month** for a 28-day supply, and it is the same across all dose strengths, from 2.5 mg up to 15 mg, per [Lilly's pricing information](https://pricinginfo.lilly.com/zepbound). That list price, also called the wholesale acquisition cost, is what Lilly charges wholesalers before any insurance, discount, or savings program is applied.

Here is the part that matters: for the average patient, the list price is close to fiction. It is the starting point for negotiations among the manufacturer, insurers, and pharmacy benefit managers, not the number most people hand over at the counter. It is worth knowing because it is what a pharmacy rings up when Zepbound is run with no coverage and no program attached, and because it sets the baseline that every cheaper route is measured against.

Zepbound comes as a single-dose pen and as a single-dose vial for once-weekly injection, in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg strengths. The dose you start on is not the dose you stay on: a typical plan titrates upward over several weeks, and that detail matters for your budget, because some price offers are tied to specific doses and to staying on schedule.

## What affects the price of Zepbound

Almost nobody pays the list price, so the real question is which of the lower numbers applies to you. Three things decide it: whether you use insurance, which manufacturer program you qualify for, and which dose you are on.

If you have commercial drug insurance that covers Zepbound, the Lilly Zepbound Savings Card can bring your cost down to **as little as $25** for a one- or three-month supply of the single-dose pens, per [Lilly's pricing information](https://pricinginfo.lilly.com/zepbound). That figure comes with real conditions, and they are easy to miss. The card requires commercial insurance that already covers the drug; it excludes anyone on a government program such as Medicare or Medicaid; the savings are capped on a monthly and annual basis; and Lilly can change or end the program at any time. The savings card is not insurance, and it does not promise you will pay $25.

Coverage itself is the bigger variable. Many commercial plans still exclude weight-management medications entirely, and the plans that do cover Zepbound often require prior authorization, meaning your clinician has to document that you meet the criteria before the plan pays. Whether a plan covers Zepbound can also depend on the reason it is prescribed. Zepbound is FDA-approved for chronic weight management and, separately, for moderate-to-severe obstructive sleep apnea in adults with obesity, the first medication the FDA has approved for that condition, per the [FDA](https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea). It is not approved for type 2 diabetes; that is Mounjaro, which contains the same molecule but is a different product. GLP-1 medications are FDA-approved for specific indications, and eligibility is determined by a licensed clinician.

## Cash-pay and lower-cost routes

If you are not going through insurance, you are not stuck with the list price either. As of 2026, Lilly sells Zepbound directly to cash-paying patients through its Zepbound Self Pay program, and the single-dose vials are the lowest-cost brand route.

| How you buy | Price without insurance (28-day supply) | Source |
|---|---|---|
| Retail pharmacy, no program | near list price, ~$1,086 | [Lilly pricing info](https://pricinginfo.lilly.com/zepbound) |
| Zepbound Self Pay, single-dose vials | ~$299 (2.5 mg), ~$399 (5 mg), ~$449 (7.5 mg and up) | [Zepbound coverage & savings](https://zepbound.lilly.com/coverage-savings) |
| GoodRx coupon (brand) | as low as ~$995 | [GoodRx](https://www.goodrx.com/zepbound) |

Two details are worth pinning down. First, the self-pay vial prices carry a refill condition: to keep them, you generally have to complete each refill within 45 days of your previous one. Miss that window and the regular, higher self-pay prices apply, so budget for the price that holds if life gets in the way of the schedule. Second, those vial prices are dose-dependent, which is why the lowest figure belongs to the starting dose and the maintenance doses cost more.

That is the brand picture. There is also a different model worth understanding, which is transparent cash-pay telehealth. Instead of a discount on a branded product, it is a care program with the price stated up front. The value is what surrounds the prescription: a physician-led team reviews your health history and eligibility before anything is prescribed, [REMEVi's transparent pricing](/pricing/) means the number you see is the number you pay with no insurance call and no prior-authorization wait, medications ship from verified US pharmacies, and a care coordinator stays with you through the early titration weeks when questions actually come up. If you want the pharmacology behind the molecule first, start with [tirzepatide, explained](/tirzepatide/).

Some telehealth programs work with compounded tirzepatide when a licensed provider decides it is appropriate for the individual patient, and it is worth being precise about what that means. Compounded tirzepatide is a non-FDA-approved preparation prepared by a state-licensed US compounding pharmacy under an individual prescription from a licensed provider. It is not a generic version of, and is not the same as, Zepbound® or Mounjaro®. Compounded preparations have not been clinically studied as finished products. A licensed clinician should walk you through that distinction before you choose any route.

## Zepbound, Mounjaro, and tirzepatide: don't mix them up

A lot of the price confusion online comes from treating three different things as one. Tirzepatide is the molecule, a single medicine that activates two gut-hormone receptors, GIP and GLP-1. Zepbound and Mounjaro are two FDA-approved Eli Lilly products that both contain it, but they are approved for different uses: Zepbound for chronic weight management and obstructive sleep apnea, Mounjaro for type 2 diabetes. Because the FDA-approved indication drives coverage, the same molecule can be covered, denied, or priced differently depending on which product is prescribed and why.

If your real comparison is tirzepatide against semaglutide, that is a separate decision with its own trade-offs in dosing, side effects, and cost. The plain-language version is here: [semaglutide vs tirzepatide](/semaglutide-vs-tirzepatide/). And if you are pricing out the semaglutide side as well, see [how much Wegovy costs](/blog/how-much-does-wegovy-cost/) for the parallel breakdown.

## The bottom line

As of 2026, Zepbound's list price is about $1,086 a month, but almost no one pays it. With commercial insurance that covers the drug, Lilly's savings card can bring it to as little as $25 a month, with conditions. Without insurance, Lilly's Zepbound Self Pay vials run roughly $299 to $449 a month depending on the dose, provided you stay on the 45-day refill schedule, and a GoodRx coupon puts the brand near $995. The right move is to confirm your coverage, your indication, and your long-term maintenance-dose cost before you commit to any route.

If you would rather have a clinician walk you through it than decode a formulary alone, that is what we are here for. **Your Health. Your Terms.** Real doctors. Real care. [remevihealth.com](/pricing/)

---

*This article is for general information and does not constitute medical advice. GLP-1 medications are FDA-approved for specific indications, and eligibility is determined by a licensed clinician. Compounded tirzepatide is a non-FDA-approved preparation prepared by a state-licensed US compounding pharmacy under an individual prescription from a licensed provider. It is not a generic version of, and is not the same as, Zepbound® or Mounjaro®. Compounded preparations have not been clinically studied as finished products. Prices cited are as of 2026, come from the named sources, and are subject to change without notice. Consult a licensed provider before starting any prescription treatment.*

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "MedicalWebPage",
  "@id": "https://remevihealth.com/blog/how-much-does-zepbound-cost/#webpage",
  "url": "https://remevihealth.com/blog/how-much-does-zepbound-cost/",
  "name": "How Much Does Zepbound Cost in 2026?",
  "inLanguage": "en-US",
  "description": "How much does Zepbound cost in 2026? List price, savings-card limits, and lower-cost cash-pay routes. Compare your options with a clinician.",
  "datePublished": "2026-06-30",
  "dateModified": "2026-06-30",
  "reviewedBy": {
    "@type": "Person",
    "name": "Linda West-Conforti, RN"
  },
  "publisher": {
    "@type": "Organization",
    "name": "REMEVi Health",
    "url": "https://remevihealth.com"
  },
  "about": {
    "@type": "Drug",
    "name": "Zepbound (tirzepatide)",
    "nonProprietaryName": "tirzepatide"
  },
  "lastReviewed": "2026-06-30"
}
</script>